Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

Saskia Litiere, Gustavo Werutsky, Ian Fentiman, Emiel Rutgers, Marie-Rose Christiaens, Erik Van Limbergen, Margreet H. A. Baaijens, Jan Bogaerts, Harry Bartelink*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    424 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial'. Together they form a unique fingerprint.

    Medicine and Dentistry